Christopher W. Cluff

Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer’s disease-related pathology

Jean-Philippe Michaud, Maxime Hallé, Antoine Lampron et al. · Proceedings of the National Academy of Sciences · 2013 · 247 citations · Full text

Monophosphoryl Lipid A (MPL) as an Adjuvant for Anti-Cancer Vaccines: Clinical Results

Christopher W. Cluff · Advances in experimental medicine and biology · 2009 · 202 citations

Vaccination, Mucosal Vaccination, Vaccine Research +13

Structure-Activity Relationship of Synthetic Toll-like Receptor 4 Agonists

Axel G. Stöver, Jean da Silva Correia, Jay T. Evans et al. · Journal of Biological Chemistry · 2004 · 156 citations · Full text

Synthetic Toll-Like Receptor 4 Agonists Stimulate Innate Resistance to Infectious Challenge

Christopher W. Cluff, Jory R. Baldridge, Axel G. Stöver et al. · Infection and Immunity · 2005 · 109 citations · Full text

Inflammation, Toll-like Receptors, Compound Family +14

Cyclosporine inhibits macrophage-mediated antigen presentation.

D A Palay, Christopher W. Cluff, Paul Wentworth et al. · The Journal of Immunology · 1986 · 92 citations

Inflammation, Drug Pretreatment, Autoimmune Disease +15